# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-046796
Filing Date
2024-05-28
Accepted
2024-05-28 07:14:29
Documents
6
Period of Report
2024-05-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0206851-6k_neurose.htm | 6-K | 10552
2 | NOTICE AND PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE | ea020685101ex99-1_neurose.htm | EX-99.1 | 104678
3 | PROXY CARD | ea020685101ex99-2_neurose.htm | EX-99.2 | 1815
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 9127
5 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 752633
6 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 520994
| Complete submission text file | 0001213900-24-046796.txt |  | 1885103

Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41084 | Film No.: 24986259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)